Podcast Medicom Medical Publishers

EAN 2020 Virtual Meeting - Highlights

May 27, 2020 Medicom Medical Publishers
Podcast Medicom Medical Publishers
EAN 2020 Virtual Meeting - Highlights
Chapters
0:17
Long-term safety of ND0612 in idiopathic Parkinson’s disease
3:17
Reassuring real-world safety profile of 3 CGRP inhibitors
5:24
Long-term cardiovascular safety of erenumab in migraine patients
7:24
Extubation after thrombectomy: the sooner, the better
10:25
Serum NfL predicts long-term clinical outcomes in MS
13:27
Neurological manifestations of COVID-19 in Europe
Podcast Medicom Medical Publishers
EAN 2020 Virtual Meeting - Highlights
May 27, 2020
Medicom Medical Publishers

Summary of 6 articles presented at the EAN 2020 Virtual Meeting:

  1. Long-term safety of ND0612 in idiopathic Parkinson’s disease
  2. Reassuring real-world safety profile of 3 CGRP inhibitors
  3. Long-term cardiovascular safety of erenumab in migraine patients
  4. Extubation after thrombectomy: the sooner, the better
  5. Serum NfL predicts long-term clinical outcomes in MS
  6. Neurological manifestations of COVID-19 in Europe


Show Notes Chapter Markers

Summary of 6 articles presented at the EAN 2020 Virtual Meeting:

  1. Long-term safety of ND0612 in idiopathic Parkinson’s disease
  2. Reassuring real-world safety profile of 3 CGRP inhibitors
  3. Long-term cardiovascular safety of erenumab in migraine patients
  4. Extubation after thrombectomy: the sooner, the better
  5. Serum NfL predicts long-term clinical outcomes in MS
  6. Neurological manifestations of COVID-19 in Europe


Long-term safety of ND0612 in idiopathic Parkinson’s disease
Reassuring real-world safety profile of 3 CGRP inhibitors
Long-term cardiovascular safety of erenumab in migraine patients
Extubation after thrombectomy: the sooner, the better
Serum NfL predicts long-term clinical outcomes in MS
Neurological manifestations of COVID-19 in Europe